Comprehensive review on Alzheimer's disease: causes and treatment

Z Breijyeh, R Karaman - Molecules, 2020 - mdpi.com
Alzheimer's disease (AD) is a disorder that causes degeneration of the cells in the brain and
it is the main cause of dementia, which is characterized by a decline in thinking and …

Brain metabolism in Alzheimer's disease: biological mechanisms of exercise

L Xu, R Liu, Y Qin, T Wang - Translational neurodegeneration, 2023 - Springer
Alzheimer's disease (AD) is a major subtype of neurodegenerative dementia caused by long-
term interactions and accumulation of multiple adverse factors, accompanied by …

APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function

M Xiong, H Jiang, JR Serrano, ER Gonzales… - Science translational …, 2021 - science.org
The ε4 allele of the apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-
onset Alzheimer's disease (AD) and greatly influences the development of amyloid-β (Aβ) …

Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease

E Horgusluoglu, R Neff, WM Song… - Alzheimer's & …, 2022 - Wiley Online Library
Metabolites, the biochemical products of the cellular process, can be used to measure
alterations in biochemical pathways related to the pathogenesis of Alzheimer's disease …

Emerging risk biomarkers in cardiovascular diseases and disorders

RK Upadhyay - Journal of lipids, 2015 - Wiley Online Library
Present review article highlights various cardiovascular risk prediction biomarkers by
incorporating both traditional risk factors to be used as diagnostic markers and recent …

ApoE lipidation as a therapeutic target in Alzheimer's disease

MF Lanfranco, CA Ng, GW Rebeck - International journal of molecular …, 2020 - mdpi.com
Apolipoprotein E (APOE) is the major cholesterol carrier in the brain, affecting various
normal cellular processes including neuronal growth, repair and remodeling of membranes …

Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease

NF Fitz, KN Nam, CM Wolfe, F Letronne… - Nature …, 2021 - nature.com
APOE and Trem2 are major genetic risk factors for Alzheimer's disease (AD), but how they
affect microglia response to Aβ remains unclear. Here we report an APOE isoform-specific …

The role of APOE and TREM2 in Alzheimer′ s disease—current understanding and perspectives

CM Wolfe, NF Fitz, KN Nam, I Lefterov… - International journal of …, 2018 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia worldwide. The extracellular
deposits of Amyloid beta (Aβ) in the brain—called amyloid plaques, and neurofibrillary …

Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

F Liao, H Yoon, J Kim - Current opinion in lipidology, 2017 - journals.lww.com
Emerging data suggest that ApoE affects several amyloid β-independent pathways. These
underexplored pathways may provide new insights into Alzheimer's disease pathogenesis …

Intracellular cholesterol trafficking and impact in neurodegeneration

F Arenas, C Garcia-Ruiz… - Frontiers in molecular …, 2017 - frontiersin.org
Cholesterol is a critical component of membrane bilayers where it plays key structural and
functional roles by regulating the activity of diverse signaling platforms and pathways …